Skip to content
Tuesday, November 17, 2026 Market moodBearish−20.9
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Breaking
BUSINESS INSIDER Interior designers share 6 things you should never have in your bedroom Neutral TECHCRUNCH Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials Bullish THE VERGE This E Ink photo frame can double as your family’s digital dashboard Neutral NEW YORK TIMES ECONOMY Fed Governor Cook Won’t Attend White House Hearing Without Changes Neutral CBS NEWS JPMorganChase initiative aims to help Americans achieve homeownership Neutral MARKET WATCH SpaceX got a vote of confidence from Nvidia ahead of Jensen Huang’s exit Strong Bullish NORTHERN MINER Canada widens tariff relief on Chinese metals Bullish COINTELEGRAPH Solana Foundation takes majority interest in crypto data firm CoinGecko Neutral WSJ ECONOMY Canada Housing Starts Fall 2.2% in October Bearish ABC NEWS Shoppers slowed spending in October with high prices leading to caution Pessimistic MARKET WATCH I tried TikTok’s viral ‘corporate slop lunch hacks’ — and finally escaped the $20 desk sa… Neutral NEW YORK POST BUSINESS Best silver IRA companies for November 2026 Strong Bullish NEW YORK TIMES BUSINESS Trump’s New A.I. Chip Rules Rattle Southeast Asia Pessimistic DEFENSE NEWS Pentagon fails ninth straight audit despite progress in organizing finances Pessimistic CNBC TOP STORIES Anthropic likely to price IPO above the current range of $70 to $78, sources tell CNBC Neutral CBS NEWS Olivia Munn and Alison Hall discuss fighting for breast cancer awareness on Capitol Hill Bullish MARKET WATCH U.S. retail sales slow just ahead of the holiday shopping season. A hint of trouble? Nope. Neutral NEW YORK POST BUSINESS Cyberattack hits 178 major websites including CNN and Zoom in bid to steal crypto, infect… Neutral THE VERGE Get ready for a nationwide emergency alert test at 2:20PM ET today Pessimistic TECHCRUNCH Science Corporation’s brain tech is worth $3.5 billion after new funding Neutral BUSINESS INSIDER Interior designers share 6 things you should never have in your bedroom Neutral TECHCRUNCH Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials Bullish THE VERGE This E Ink photo frame can double as your family’s digital dashboard Neutral NEW YORK TIMES ECONOMY Fed Governor Cook Won’t Attend White House Hearing Without Changes Neutral CBS NEWS JPMorganChase initiative aims to help Americans achieve homeownership Neutral MARKET WATCH SpaceX got a vote of confidence from Nvidia ahead of Jensen Huang’s exit Strong Bullish NORTHERN MINER Canada widens tariff relief on Chinese metals Bullish COINTELEGRAPH Solana Foundation takes majority interest in crypto data firm CoinGecko Neutral WSJ ECONOMY Canada Housing Starts Fall 2.2% in October Bearish ABC NEWS Shoppers slowed spending in October with high prices leading to caution Pessimistic MARKET WATCH I tried TikTok’s viral ‘corporate slop lunch hacks’ — and finally escaped the $20 desk sa… Neutral NEW YORK POST BUSINESS Best silver IRA companies for November 2026 Strong Bullish NEW YORK TIMES BUSINESS Trump’s New A.I. Chip Rules Rattle Southeast Asia Pessimistic DEFENSE NEWS Pentagon fails ninth straight audit despite progress in organizing finances Pessimistic CNBC TOP STORIES Anthropic likely to price IPO above the current range of $70 to $78, sources tell CNBC Neutral CBS NEWS Olivia Munn and Alison Hall discuss fighting for breast cancer awareness on Capitol Hill Bullish MARKET WATCH U.S. retail sales slow just ahead of the holiday shopping season. A hint of trouble? Nope. Neutral NEW YORK POST BUSINESS Cyberattack hits 178 major websites including CNN and Zoom in bid to steal crypto, infect… Neutral THE VERGE Get ready for a nationwide emergency alert test at 2:20PM ET today Pessimistic TECHCRUNCH Science Corporation’s brain tech is worth $3.5 billion after new funding Neutral
Wired · Oct 24, 2026 11:30 AM EDT Not market news

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Image Wired

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE